|
⚲
|
| Keyboard |
| Ward Keith Wayne
✚
|
|
|---|---|
| CIK # | 0001662394 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001662394] | |
| 4 | [0001662394] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ward Keith Wayne | |
| Skye Bioscience Inc | |
| Reata Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
|
2024-02-29 | Grant | 35,000 | $0.00 | |
|
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
|
2023-11-06 | Grant | 14,110 | $0.00 | |
|
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
|
2023-08-25 | Grant | 1,472,692 | $0.00 | |
|
Skye Bioscience Inc SKYE
Stock Option (Right to Buy) · derivative
|
2023-01-05 | Grant | 250,000 | $0.00 | |
|
Skye Bioscience Inc SKYE
Director Option Grant (Right to Buy) · derivative
|
2021-12-14 | Grant | 250,000 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-02-26 | Conversion | 25,184 | ||
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2019-02-26 | Option exercise | 8,367 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-02-26 | Option exercise | 8,367 | $11.62 | 97,225 |
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-02-26 | Option exercise | 16,817 | $11.00 | 184,987 |
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2019-02-26 | Option exercise | 16,817 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-02-26 | Sell | 16,817 | $91.00 | 1,530,347 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-02-26 | Sell | 8,367 | $91.62 | 766,585 |
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-02-26 | Conversion | 25,184 | ||
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2019-02-25 | Option exercise | 15,183 | $0.00 | |
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-02-25 | Conversion | 15,183 | ||
|
Reata Pharmaceuticals Inc RETA
Class B common stock · derivative
|
2019-02-25 | Option exercise | 15,183 | $11.00 | 167,013 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-02-25 | Sell | 15,183 | $91.00 | 1,381,653 |
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-02-25 | Conversion | 15,183 | ||
|
Reata Pharmaceuticals Inc RETA
Class A common stock
|
2019-01-31 | Sell | 1,400 | $76.17 | 106,638 |
|
Reata Pharmaceuticals Inc RETA
Employee Stock Option (right to buy) · derivative
|
2019-01-31 | Option exercise | 4,150 | $0.00 | |
| showing 20 of 64 most recent transactions | |||||